30.51
-0.01(-0.03%)
Currency In USD
| Previous Close | 30.52 |
| Open | 30.26 |
| Day High | 30.9 |
| Day Low | 29.2 |
| 52-Week High | 62.53 |
| 52-Week Low | 24.1 |
| Volume | 725,827 |
| Average Volume | 1.01M |
| Market Cap | 2.86B |
| PE | -8.03 |
| EPS | -3.8 |
| Moving Average 50 Days | 31.33 |
| Moving Average 200 Days | 44.43 |
| Change | -0.01 |
If you invested $1000 in Crinetics Pharmaceuticals, Inc. (CRNX) since IPO date, it would be worth $1,244.8 as of June 01, 2025 at a share price of $30.51. Whereas If you bought $1000 worth of Crinetics Pharmaceuticals, Inc. (CRNX) shares 5 years ago, it would be worth $1,932.24 as of June 01, 2025 at a share price of $30.51.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
GlobeNewswire Inc.
May 23, 2025 12:00 PM GMT
SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies Global Healthcare Conference, taking place June 3-5, 2025 in New York, NY. Jefferi
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
GlobeNewswire Inc.
May 15, 2025 8:05 PM GMT
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of-Care Discontinuation Rates SAN
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
May 12, 2025 8:05 PM GMT
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate